Tag: https://www.bio.org/events/bio-international-convention
We need to make progress against the next pandemic, Phyllis Arthur, Senior Vice President of Infectious Diseases & Emerging … source
Bipartisan agreement is rare these days, but members of both sides of the aisle agree on one thing: it’s time to reform the way … source
With the deadly threat of drug-resistant infections increasing daily, we desperately need actions to address the broken commercial marketplace for novel antimicrobials—including the PASTEUR Act, a novel pull incentive, and reforms to antimicrobial reimbursement—said a CEO speaking on behalf of the Biotechnology Innovation Organization (BIO) and the Antimicrobials Working Group (AWG) at a July 11 […]
The House Energy and Commerce Health Subcommittee held a hearing entitled “Innovation Saves Lives: Evaluating Medicare Coverage Pathways for Innovative Drugs, Medical Devices, and Technology,” focusing on how the Centers for Medicare & Medicaid Services (CMS) defines “reasonable and necessary” criteria for Medicare coverage, the recent national coverage determination (NCD) policy for Alzheimer’s disease drugs, […]
It’s a big week for the Pandemic All-Hazards Preparedness Act (PAHPA)…and the biotech and biodefense industry is watching … source
In a big week for reauthorization of the Pandemic All Hazards and Preparedness Act (PAHPA), versions of the legislation were approved by a House committee on July 19 and a Senate committee on July 20. Here’s what happened and why it matters. PAHPA establishes measures to prepare for the next pandemic and “allows us to […]
Rep. Scott Peters (D-CA) criticized the PAHPA bill for not including the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act, of which he is one of the House sponsors. The Senate sponsors of the bill to address antimicrobial resistance have also been pushing for its inclusion in PAHPA, which now seems unlikely. July 20, […]